Modus Therapeutics

About:

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Website: http://www.modustx.com/

Twitter/X: Modustx

Top Investors: HealthCap, Rosetta Capital, Karolinska, Praktikerinvest, Ostersjöstiftelsen

Description:

Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.